Cargando…
Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review
BACKGROUND: Patients with chronic kidney disease (CKD) may need to have their radiopharmaceutical dosage adjusted to prevent adverse effects and poor outcomes, but there are few recommendations on radiopharmaceutical dosing for this group of patients. The aim of this study is to provide an overview...
Autores principales: | Schreuder, Nanno, de Romijn, Iris, Jager, Pieter L., Kosterink, Jos G. W., van Puijenbroek, Eugène P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380202/ https://www.ncbi.nlm.nih.gov/pubmed/34417933 http://dx.doi.org/10.1186/s41181-021-00145-w |
Ejemplares similares
-
Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
por: Schreuder, Nanno, et al.
Publicado: (2020) -
Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
por: Schreuder, Nanno, et al.
Publicado: (2020) -
Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?
por: Schreuder, Nanno, et al.
Publicado: (2020) -
Anaphylactic Reaction to Tc-99m Macrosalb
por: Schreuder, Nanno, et al.
Publicado: (2019) -
Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review
por: van der Pol, Jochem, et al.
Publicado: (2017)